Skip to content

Athero-thrombosis risk in patients with venous thrombo-embolism

Athero-thrombosis risk in patients with venous thrombo-embolism - ATRISK Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34860
Enrollment
161
Registered
2010-03-15
Start date
2010-02-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular disease venous thrombo-embolism

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All consecutive patients between 40 and 79 years old who previously presented themselves at the Slotervaart hospital in Amsterdam and the Academic Medical Centre in Amsterdam with an objectified first or recurrent episode of deep vein thrombosis or pulmonary embolism will be included.

Exclusion criteria

Exclusion criteria: All patients younger than 40 years and older than 79 years of age will be excluded.

Design outcomes

Primary

MeasureTime frame
The proportion of VTE patients who are at risk for future cardiovascular events.

Secondary

MeasureTime frame
- The proportion of VTE patients who have an increased risk of cardiovascular disease that was not previously recognized. - The frequency of an unfavourable cardiovascular risk profile in patients with an unprovoked VTE compared to those with provoked VTE.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)